EA
41
3
WM
53
2
UAL
73
3
EW
55
5
ES
12
3
EXPD
29
2
NEM
30
2
AON
25
4
A
43
2
HBAN
47
7
ICE
53
5
FCX
44
4
MAC
53
5
MCD
52
3
GIS
47
13
CMA
42
3
SRE
37
9
SO
48
6
LB
16
9
DNB
72
4
EA
41
3
WM
53
2
UAL
73
3
EW
55
5
ES
12
3
EXPD
29
2
NEM
30
2
AON
25
4
A
43
2
HBAN
47
7
ICE
53
5
FCX
44
4
MAC
53
5
MCD
52
3
GIS
47
13
CMA
42
3
SRE
37
9
SO
48
6
LB
16
9
DNB
72
4
Financhill
Back

Monte Rosa Therapeutics Vs. Evoke Pharma Industry Stock Comparison

Sell
21

GLUE
Monte Rosa Therapeutics

Last Price:
$6.92
Seasonality Move:
-3.94%
Buy
53

EVOK
Evoke Pharma

Last Price:
$5.02
Seasonality Move:
1.96%
Sell
21
Monte Rosa Therapeutics (GLUE) is a Sell

Is Monte Rosa Therapeutics a Buy, Sell or Hold?

  • The current Monte Rosa Therapeutics [GLUE] share price is $6.91. The Score for GLUE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • GLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Evoke Pharma (EVOK) is a Buy

Is Evoke Pharma a Buy, Sell or Hold?

  • The current Evoke Pharma [EVOK] share price is $5.09. The Score for EVOK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • EVOK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GLUE Stock Price Chart

What is Monte Rosa Therapeutics's stock price today?

  • The Monte Rosa Therapeutics share price today is $6.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLUE is experiencing slight buying pressure.

EVOK Stock Price Chart

What is Evoke Pharma's stock price today?

  • The Evoke Pharma share price today is $5.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EVOK is experiencing slight selling pressure.

GLUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 39.42 Sell
Chaikin Money Flow: 968460 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.45 - 9.53) Sell
Bollinger Bands (100): (4.82 - 8.52) Buy

EVOK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 57.08 Buy
Chaikin Money Flow: -768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.16 - 4.76) Buy
Bollinger Bands (100): (4.26 - 5.54) Buy

GLUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.46 Sell
20-day SMA: 8.59 Sell
50-day SMA: 7.94 Sell
200-day SMA: 5.93 Buy
8-day EMA: 7.49 Sell
20-day EMA: 8.11 Sell
50-day EMA: 7.84 Sell
200-day EMA: 6.37 Buy

EVOK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.67 Buy
20-day SMA: 4.44 Buy
50-day SMA: 4.97 Buy
200-day SMA: 5.6 Sell
8-day EMA: 4.77 Buy
20-day EMA: 4.63 Buy
50-day EMA: 4.79 Buy
200-day EMA: 6.68 Sell

Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.

Evoke Pharma Earnings Growth & EVOK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.

Monte Rosa Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Evoke Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):